Cara Therapeutics To Host Virtual R&D On March 11

Cara Therapeutics, CARA known for its research on cannabinoid receptor agonists for the relief of inflammatory and neuropathic pain, will host a virtual research and development event on Friday, March 11 from 1:00 to 2:00 p.m. ET. The presentation will focus on the initiation of oral difelikefalin Phase 3 programs for the treatment of pruritus in patients with atopic dermatitis and non-dialysis dependent chronic kidney disease.

An interactive Q&A session will follow the presentation.

Presenters will include:

Christopher Posner, president & CEO and director of Cara Therapeutics

  • Joana Goncalves, MD, chief medical officer of Cara Therapeutics
  • Brian Kim, MD, MTR,
  • Jonathan Silverberg, MD, Ph.D., MPH



Market News and Data brought to you by Benzinga APIs
Posted In: CannabisNewsMarketsBrian KimChristopher PosnerJoana GoncalvesJonathan Silverberg
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Top Cannabis Event In New Jersey

Join the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money and capitalize on the booming NJ recreational market. Don’t miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code "JAVIER20" for 20% off!